Clinical trials: Seborrheic Dermatitis
Facial Aging, Facial Wrinkles and Rhytides Reduction
Intradermal Microbotulinum Toxin for Sebum Reduction and Facial Pore Improvement
This study aims to evaluate the efficacy and safety of microdoses of botulinum toxin type A (microtoxin) for improving periocular skin quality and reducing fine wrinkles.
- Trial name
- MICROTOX-PORE (NCT07526870)
- Testing
- Botulinum Toxin Type A (Dysport®)
- Where
- Mexico
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Instituto de Oftalmología Fundación Conde de Valenciana
Signs of Androgenisation in Women, e.g. Hirsutism, Androgenetic Alopecia, Acne and Seborrhea, Hypersexuality in Men
A Study to Learn About the Awareness and Knowledge That Doctors Have About the Safety and Safe Use Information for Androcur and Other Cyproterone Acetate Treatments in Europe
Androcur is a type of treatment called cyproterone acetate (CPA). Androcur and other CPA treatments work by blocking a group of male sex hormones called androgens in the body.
- Conditions
- Signs of Androgenisation in Women, e.g. Hirsutism, Androgenetic Alopecia, Acne and Seborrhea, Hypersexuality in Men, Sexual Deviations in Men, Prostate Cancer
- Trial name
- Safe-CAM (NCT04925180)
- Testing
- Cyproterone Acetate (Androcur, BAY94-8367)
- Where
- 5 sites in France, Germany and 3 more
- Volunteers
- 600 people
- Sponsor
- Bayer
Seborrheic Dermatitis
Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic Dermatitis
The purpose of this study is: 1. To determine the efficacy of photodynamic therapy (PDT) in the treatment of seborrheic dermatitis. 2.
- Trial name
- NCT03114111
- Testing
- aminolevulinic acid (ALA)
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- University of California, Davis
Seborrhea, Seborrheic Dermatitis
Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea
Oral isotretinoin is the gold standard drug to treat moderate to severe acne. Other indications like seborrhea, seborrheic dermatitis have been suggested.
- Conditions
- Seborrhea, Seborrheic Dermatitis, Quality of Life
- Trial name
- NCT01139749
- Testing
- oral isotretinoin, salicylic acid and ciclopirox olamine
- Where
- Brazil
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Federal University of São Paulo
Dermatitis, Seborrheic
STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2%
Extina (ketoconazole) Foam, 2% was approved for marketing in the United States (US) in June 2007. Extina foam is indicated for topical treatment of seborrheic dermatitis in immunocompetent patients 12 years of age and older.
- Trial name
- NCT00703846
- Testing
- Ketoconazole
- Volunteers
- 498 people
- Sponsor
- Stiefel, a GSK Company
Seborrheic Dermatitis
Safety and Efficacy of a Topical Cream in Mild-to-Moderate Seborrheic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the safety and efficacy of scalp cream for Symptom Relief and Microbiome Balance in mild-moderate Seborrheic Dermatitis patients.
- Trial name
- NCT07063615
- Testing
- Microbiome-Powered Cream
- Where
- India
- Volunteers
- 34 people
- Sponsor
- NovoBliss Research Pvt Ltd
Seborrheic Dermatitis
A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis
This is an exploratory study to determine effectiveness of Elidel for the treatment of seborrheic dermatitis
- Trial name
- NCT00403559
- Testing
- Elidel, Ketoconazole Cream
- Where
- United States
- Volunteers
- 113 people, healthy volunteers welcome
- Sponsor
- Dermatology Specialists Research
Seborrheic Dermatitis on the Face
A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face
This study is to determine whether a medication on the market for other indications is effective and safe in treating seborrheic dermatitis of the face.
- Trial name
- NCT00408330
- Testing
- Azelaic Acid 15% Gel, Inactive 15% gel base
- Where
- 4 sites in Germany
- Volunteers
- 48 people
- Sponsor
- LEO Pharma
Seborrheic Dermatitis
The Effectiveness of Itraconazole Pulse Therapy vs Topical 2% Ketoconazole in the Treatment of Moderate to Severe Seborrheic Dermatitis of Scalp.
This study is a randomized controlled trial comparing the effectiveness of oral itraconazole pulse therapy versus topical 2% ketoconazole shampoo in treating moderate to severe scalp seborrheic dermatitis (SD).
- Trial name
- NCT07734441
- Testing
- Itraconazole (200 mg), Ketoconazole 2%
- Where
- Pakistan
- Volunteers
- 80 people
- Sponsor
- Combined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan
Seborrheic Dermatitis
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis
This study is a Phase II, single center, randomized, double-blind, placebo-controlled study in male and female subjects, aged ≥ 19 years with mild to moderate seborrheic dermatitis of the face.
- Trial name
- NCT02749383
- Testing
- PAC-14028 cream 0.3%, PAC-14028 cream 1.0%, PAC-14028 cream vehicle
- Volunteers
- 75 people
- Sponsor
- Amorepacific Corporation
Parkinson Disease, Parkinsonism
Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients
There's high incidence of seborrhic dermatitis among patients suffering from Parkinson's disease. Seborrhic dermatitis is caused by increased exertion of sebaceous glands.
- Conditions
- Parkinson Disease, Parkinsonism, Seborrheic Dermatitis
- Trial name
- NCT00767546
- Testing
- Botulinum toxin
- Volunteers
- 40 people
- Sponsor
- Rabin Medical Center
Seborrheic Dermatitis, Dietary Habits
Phenotypic and Functional Profile of Peripheral Blood Lymphomonocytes in Seborrheic Dermatitis.
The protocol describes a prospective, monocentric pilot study conducted at the Istituto Dermatologico San Gallicano (IFO-ISG) aimed at investigating the phenotypic and functional profile of peripheral-blood lymphomonocytes in…
- Trial name
- PHENOTYPIC (NCT07297446)
- Where
- Italy
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- San Gallicano Dermatological Institute IRCCS
Seborrheic Dermatitis
Efficacy and Safety of ASF1057 in the Treatment of Seborrhoeic Dermatitis
A growing body of evidence supports the hypothesis that the pathophysiology of seborrhoeic dermatitis has a potentially causative neurogenic inflammatory aspect.
- Trial name
- NCT00565279
- Testing
- ASF1057
- Volunteers
- 300 people
- Sponsor
- Astion Pharma A/S
Cradle Cap, Infantile Seborrheic Dermatitis
Promiseb Topical Cream for Cradle Cap
The purpose of this study is to evaluate the efficacy and safety of Promiseb Topical Cream in cradle cap.
- Trial name
- NCT01214434
- Testing
- Promiseb Topical Cream, Bland emollient
- Where
- 4 sites in United States
- Volunteers
- 42 people
- Sponsor
- Promius Pharma, LLC
Seborrheic Dermatitis, Psoriasis of Scalp
Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of Scalp
Observational, descriptive, retrospective, multicenter study to evaluate the safety of the treatment with Sebryl® and / or Sebryl Plus® in the management of seborrheic dermatitis and psoriasis of the scalp in routine medical…
- Trial name
- NCT05105139
- Testing
- Allantoin/ Coal Tar/ Clioquinol, Allantoin/ Coal Tar/ Clioquinol/ Triclosan
- Where
- Mexico
- Volunteers
- 90 people, healthy volunteers welcome
- Sponsor
- Laboratorios Silanes S.A. de C.V.
Dermatitis, Melanoma (Skin Cancer)
Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care
This study aims to determine if an artificial intelligence (AI) medical device can help doctors more accurately identify a wide variety of skin conditions and improve the efficiency of patient consultations.
- Conditions
- Dermatitis, Melanoma (Skin Cancer), Alopecia, Urticaria
- Trial name
- LegitHealthSAN (NCT07428954)
- Testing
- AI-based medical device for aided diagnosis in Dermatology
- Where
- Spain
- Volunteers
- 16 people
- Sponsor
- AI Labs Group S.L
Rosacea, Acne Vulgaris
The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage
This study is an evaluation of the role of topical dissolved oxygen to lessen visible signs of photodamage using a select regimen of topical dissolved oxygen containing cosmeceutical products.
- Conditions
- Rosacea, Acne Vulgaris, Atopic Dermatitis, Seborrheic Dermatitis
- Trial name
- NCT00991198
- Testing
- Topical oxygen
- Where
- United States
- Volunteers
- 49 people
- Sponsor
- Aria Aesthetics Inc.
Seborrheic Dermatitis
Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM)
This phase 3, double-blind, vehicle-controlled study assessed the safety and efficacy of roflumilast (ARQ-154) foam 0.3% applied once daily (qd) for 8 weeks by participants with seborrheic dermatitis.
- Trial name
- NCT04973228
- Testing
- Roflumilast Foam, Vehicle Foam
- Where
- 53 sites in United States, Canada
- Volunteers
- 457 people
- Sponsor
- Arcutis Biotherapeutics, Inc.
Dandruff, Seborrheic Dermatitis
Cleansing Device for the Treatment of Scalp and Hair Conditions
The objective of this study is to evaluate an improvement of scalp health after the use of an investigational off-label WaterPik and brush device aimed to massage and cleanse the scalp.
- Conditions
- Dandruff, Seborrheic Dermatitis, Hair Loss
- Trial name
- NCT05319444
- Testing
- Off-brand Waterpik®
- Where
- United States
- Volunteers
- 2 people, healthy volunteers welcome
- Sponsor
- University of Minnesota
Cradle Cap, Seborrheic Dermatitis
TRIDERM D.S. Crema Normalizzante for Neonatal Hyperseborrhea (Cradle Cap) and Associated Cutaneous Manifestations of Mild-to-Moderate Seborrheic Dermatitis in Children Aged 0 to 3 Years
This clinical study aims to evaluate the effects of using the cosmetic product TRIDERM D.S. Crema Normalizzante in children aged 0 to 3 years with neonatal hyperseborrhea ("cradle cap"), potentially associated with manifestations…
- Trial name
- NCT07860788
- Testing
- TRIDERM D.S. Crema Normalizzante
- Where
- Italy
- Volunteers
- 20 people
- Sponsor
- ICIM International S.r.l.